Who are Tadalafil Pill's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/tadalafil-pill.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Tadalafil Pill — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tadalafil Pill (Tadalafil Pill) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Phosphodiesterase type 5 (PD5) inhibitor. Area: Urology, Cardiology, Pulmonology.

marketed Phosphodiesterase type 5 (PD5) inhibitor PD5 (phosphodiesterase type 5) Urology, Cardiology, Pulmonology Small molecule Live · refreshed every 30 min

Target snapshot

Tadalafil Pill (Tadalafil Pill) — Santa Barbara Cottage Hospital. Tadalafil inhibits phosphodiesterase type 5 (PD5) in the corpus cavernosum, increasing cyclic GMP levels to promote smooth muscle relaxation and improve blood flow.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Tadalafil Pill TARGET	Tadalafil Pill	Santa Barbara Cottage Hospital	marketed	Phosphodiesterase type 5 (PD5) inhibitor	PD5 (phosphodiesterase type 5)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Phosphodiesterase type 5 (PD5) inhibitor class)

Santa Barbara Cottage Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Tadalafil Pill — Competitive Intelligence Brief. https://druglandscape.com/ci/tadalafil-pill. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing